All Stories

  1. Corrigendum to “Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes”

    Article • Oxidative Medicine and Cellular Longevity, August 2018, Hindawi Publishing Corporation

    Giovanni Tarantino

  2. Phenotyping of CYP 4501A2 Activity by Total Overnight Salivary Caffeine Assessment (TOSCA) in Patients on Warfarin Treatment: A Cross-Sectional Study

    Article • Clinical and Applied Thrombosis/Hemostasis, October 2017, SAGE Publications

    Giovanni Tarantino

  3. Adherence to the Mediterranean Diet and Circulating Levels of Sirtuin 4 in Obese Patients: A Novel Association

    Article • Oxidative Medicine and Cellular Longevity, January 2017, Hindawi Publishing Corporation

    Giovanni Tarantino, Prof Annamaria AL Colao, Giovanna Muscogiuri

  4. Sublingual administration improves systemic exposure of tacrolimus in kidney transplant recipients: comparison with oral administration

    Article • European Journal of Clinical Investigation, June 2016, Wiley

    Giovanni Tarantino

  5. Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status

    Article • Growth Hormone & IGF Research, February 2015, Elsevier

    Giovanni Tarantino

  6. Carotid Intima-Media Thickness Is Predicted by Combined Eotaxin Levels and Severity of Hepatic Steatosis at Ultrasonography in Obese Patients with Nonalcoholic Fatty Liver Disease

    Article • PLoS ONE, September 2014, PLOS

    Giovanni Tarantino

  7. Gut Microbiome, Obesity-Related Comorbidities, and Low-Grade Chronic Inflammation

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2014, Endocrine Society

    Giovanni Tarantino

  8. Obesity, Lung Function, and Lung Disease

    Article • February 2014, Taylor & Francis

    Giovanni Tarantino

  9. Beyond Nutrition Is There Any Role for Physical Activity in Nonalcoholic Fatty Liver Disease Therapy?

    Article • January 2014, Elsevier

    Giovanni Tarantino

  10. Circulating Levels of Sirtuin 4, a Potential Marker of Oxidative Metabolism, Related to Coronary Artery Disease in Obese Patients Suffering from NAFLD, with Normal or Slightly Increased Liver Enzymes

    Article • Oxidative Medicine and Cellular Longevity, January 2014, Wiley

    Giovanni Tarantino

  11. Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C (and Congenital Bleeding Disorders): Where Do We Stand?

    Article • Seminars in Thrombosis and Hemostasis, September 2013, Thieme Publishing Group

    ANTONIO COPPOLA, Giovanni Tarantino

  12. Should visceral fat be reduced to increase longevity?

    Article • Ageing Research Reviews, September 2013, Elsevier

    Giovanni Tarantino

  13. Inhibition of the mTOR pathway: A possible protective role in coronary artery disease

    Article • Annals of Medicine, May 2013, Taylor & Francis

    Giovanni Tarantino

  14. Bisphenol A in polycystic ovary syndrome and its association with liver–spleen axis

    Article • Clinical Endocrinology, January 2013, Wiley

    Giovanni Tarantino

  15. Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable?

    Article • Hepatitis Monthly, January 2013, Kowsar Medical Institute

    Giovanni Tarantino

  16. Liver-spleen axis: Intersection between immunity, infections and metabolism

    Article • World Journal of Gastroenterology, January 2013, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Giovanni Tarantino

  17. Exposure to ambient air particulate matter and non-alcoholic fatty liver disease

    Article • World Journal of Gastroenterology, January 2013, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Giovanni Tarantino

  18. What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

    Article • World Journal of Gastroenterology, January 2013, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Giovanni Tarantino

  19. Pathogenesis of hepatic steatosis: The link between hypercortisolism and non-alcoholic fatty liver disease

    Article • World Journal of Gastroenterology, January 2013, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Giovanni Tarantino

  20. Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?

    Article • Hepatology International, October 2012, Springer Science + Business Media

    Giovanni Tarantino

  21. Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?

    Article • Journal of Translational Medicine, March 2012, Springer Science + Business Media

    Giovanni Tarantino

  22. Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study

    Article • Arthritis Research & Therapy, January 2012, Springer Science + Business Media

    Giovanni Tarantino

  23. Analytical and Pharmacological Aspects of Therapeutic Drug Monitoring of mTOR Inhibitors

    Article • Current Drug Metabolism, March 2011, Bentham Science Publishers

    Giovanni Tarantino

  24. Spleen: A new role for an old player?

    Article • World Journal of Gastroenterology, January 2011, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Giovanni Tarantino

  25. Is spleen circulation impaired in systemic sclerosis and what is the role of liver fibrosis?

    Article • World Journal of Gastroenterology, January 2011, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Giovanni Tarantino

  26. Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease

    Article • World Journal of Gastroenterology, January 2011, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Giovanni Tarantino

  27. JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease

    Article • World Journal of Gastroenterology, January 2011, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Giovanni Tarantino

  28. Absence of Pharmacokinetic Interference of Moxifloxacin on Cyclosporine and Tacrolimus in Kidney Transplant Recipients

    Article • The Journal of Clinical Pharmacology, May 2010, Wiley

    Giovanni Tarantino

  29. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance

    Article • World Journal of Gastroenterology, January 2010, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Giovanni Tarantino

  30. What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis?

    Article • BMC Gastroenterology, November 2009, Springer Science + Business Media

    Giovanni Tarantino

  31. EC‐MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF‐related gastrointestinal side‐effects

    Article • Fundamental and Clinical Pharmacology, September 2009, Wiley

    Giovanni Tarantino

  32. Could inflammatory markers help diagnose nonalcoholic steatohepatitis?

    Article • European Journal of Gastroenterology & Hepatology, May 2009, Wolters Kluwer Health

    Giovanni Tarantino

  33. Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins

    Article • BMC Gastroenterology, March 2009, Springer Science + Business Media

    Giovanni Tarantino

  34. Drug-induced liver injury: Is it somehow foreseeable?

    Article • World Journal of Gastroenterology, January 2009, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Giovanni Tarantino

  35. Could quantitative liver function tests gain wide acceptance among hepatologists?

    Article • World Journal of Gastroenterology, January 2009, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Giovanni Tarantino

  36. Drug-induced liver injury due to “natural products” used for weight loss: A case report

    Article • World Journal of Gastroenterology, January 2009, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Giovanni Tarantino

  37. Hepatic steatosis in overweight/obese females: New screening method for those at risk

    Article • World Journal of Gastroenterology, January 2009, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Giovanni Tarantino

  38. Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?

    Article • Journal of Inflammation, January 2009, Springer Science + Business Media

    Giovanni Tarantino

  39. Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

    Article • Journal of Translational Medicine, November 2008, Springer Science + Business Media

    Giovanni Tarantino

  40. Is there a direct role of hepatitis C virus in portosystemic encephalopathy?

    Article • Journal of Gastroenterology, March 2008, Springer Science + Business Media

    Giovanni Tarantino

  41. Extensive psoriasis induced by pegylated interferon: a case report

    Article • Journal of Medical Case Reports, September 2007, Springer Science + Business Media

    Giovanni Tarantino

  42. Incidence of hypertension in individuals with different blood pressure salt-sensitivity: results of a 15-year follow-up study

    Article • Journal of Hypertension, July 2007, Wolters Kluwer Health

    Giovanni Tarantino

  43. A prospective study of acute drug‐induced liver injury in patients suffering from non‐alcoholic fatty liver disease

    Article • Hepatology Research, May 2007, Wiley

    Giovanni Tarantino

  44. Utility of Sonography in Diagnosing Hepatocellular Carcinoma

    Article • American Journal of Roentgenology, May 2007, American Roentgen Ray Society

    Giovanni Tarantino

  45. A Pharmacokinetic Interaction Between Clarithromycin and Sirolimus in Kidney Transplant Recipient

    Article • Current Drug Metabolism, May 2007, Bentham Science Publishers

    Giovanni Tarantino

  46. Non‐alcoholic fatty liver disease: Further expression of the metabolic syndrome

    Article • Journal of Gastroenterology and Hepatology, February 2007, Wiley

    Giovanni Tarantino

  47. Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection

    Article • Journal of Gastroenterology, January 2007, Springer Science + Business Media

    Giovanni Tarantino

  48. Reliability of total overnight salivary caffeine assessment (TOSCA) for liver function evaluation in compensated cirrhotic patients

    Article • European Journal of Clinical Pharmacology, July 2006, Springer Science + Business Media

    Giovanni Tarantino

  49. Metabolic factors involved in the therapeutic response of patients with hepatitis C virus‐related chronic hepatitis

    Article • Journal of Gastroenterology and Hepatology, July 2006, Wiley

    Giovanni Tarantino

  50. Is NAFLD an Incidentaloma?

    Article • Gastroenterology, March 2006, Elsevier

    Giovanni Tarantino

  51. The use of interferon-?? in a small cohort of patients with a type of idiopathic pulmonary fibrosis, probably post-cryoglobulinaemia, hepatitis C virus related

    Article • European Journal of Gastroenterology & Hepatology, December 2005, Wolters Kluwer Health

    Giovanni Tarantino

  52. Is the quality of life always depressed in patients with chronic hepatitis C on antiviral therapy?

    Article • European Journal of Gastroenterology & Hepatology, September 2005, Wolters Kluwer Health

    Giovanni Tarantino

  53. Insulin Resistance and Hepatitis C

    Article • Gastroenterology, June 2005, Elsevier

    Giovanni Tarantino

  54. Silent non-alcoholic fatty liver disease—a clinical–histological study

    Article • Journal of Hepatology, November 2004, Elsevier

    Giovanni Tarantino

  55. The role of alcoholic and metabolic co-factors in chronic hepatitis C

    Article • Gastroenterology, June 2004, Elsevier

    Giovanni Tarantino

  56. Abnormally high resistive index of central retinal artery by ultrasound color Doppler in patients with viral chronic liver disease: correlation with worsening liver staging

    Article • Ultrasound in Medicine & Biology, May 2004, Elsevier

    Giovanni Tarantino

  57. Cytokine network during NASH and possible treatment selection

    Article • Hepatology, August 2003, Wolters Kluwer Health

    Giovanni Tarantino

  58. Haemostasis Unbalance in Pugh-Scored Liver Cirrhosis: Characteristic Changes of Plasma Levels of Protein C versus Protein S

    Article • Pathophysiology of Haemostasis and Thrombosis, January 1993, Karger Publishers

    Giovanni Tarantino